scispace - formally typeset
Journal ArticleDOI

The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines.

Reads0
Chats0
TLDR
Recommendations are provided regarding pharmacologic interactions that may occur during combination therapy with warfarin, clopidogrel and proton-pump inhibitors, or acetylsalicylic acid and nonsteroidal anti-inflammatory drugs, as well as for the management of bleeding complications.
About
This article is published in Canadian Journal of Cardiology.The article was published on 2011-05-01. It has received 129 citations till now. The article focuses on the topics: Clopidogrel & Canadian Cardiovascular Society.

read more

Citations
More filters
Journal Article

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

TL;DR: In patients 75 years of age or younger who have myocardial infarction with ST-segment elevation and who receive aspirin and a standard fibrinolytic regimen, the addition of clopidogrel improves the patency rate of the infarct-related artery and reduces ischemic complications.
Journal ArticleDOI

The Transfer of Drugs and Therapeutics Into Human Breast Milk: An Update on Selected Topics

Hari Cheryl Sachs
- 01 Sep 2013 - 
TL;DR: This report discusses several topics of interest surrounding lactation, such as the use of psychotropic therapies, drugs to treat substance abuse, narcotics, galactagogues, and herbal products, as well as immunization of breastfeeding women.

Excess risk of fatal coronary heart disease associated with diabetes in men and women:meta-analysis of 37 prospective cohort studies

PO Box
TL;DR: The relative risk for fatal coronary heart disease associated with diabetes is 50% higher in women than it is in men, and this greaterexcess coronary risk may be explained by more adverse cardiovascular risk profiles among women with diabetes, combined with possible disparities in treatment that favour men.
References
More filters
Journal ArticleDOI

Diagnosis and Management of the Metabolic Syndrome An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

TL;DR: This statement from the American Heart Association and the National Heart, Lung, and Blood Institute is intended to provide up-to-date guidance for professionals on the diagnosis and management of the metabolic syndrome in adults.
Journal ArticleDOI

ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation

TL;DR: The once-in-a-lifetime treatment with Abciximab Intracoronary for acute coronary syndrome and a second dose intravenously for atrial fibrillation is recommended for adults with high blood pressure.
Journal ArticleDOI

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

TL;DR: The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.
Journal ArticleDOI

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

TL;DR: The goals of this new consensus are to provide an abbreviated document to focus on key aspects of diagnosis and management, and to update the information based on new publications and the newer guidelines, but not to add an extensive list of references.
Related Papers (5)